| Name | Title | Contact Details |
|---|
Since 1950, United Community has been dedicated to providing best-in-class service to our customers as the foundation of every relationship. Were proud to have won several awards for our service. In eight of the last ten years, J.D. Power ranked United highest in customer satisfaction with retail banking in the Southeast. Forbes included United in its inaugural list of the Worlds Best Banks in 2019, and again in 2020, 2022 and 2023. We were also recognized on the Forbes 2020 list of the 100 Best Banks in America for the seventh consecutive year. We received five Greenwich Excellence Awards in 2019 for excellence in Small Business Banking and Middle Market Banking, including a national award for Overall Satisfaction in Small Business Banking. Were honored to be recognized as a great place to work, too. In 2020, we were designated one of the Top Workplaces in South Carolina (Greenville Business Magazine) and Atlanta (Atlanta Journal-Constitution). With more than 200 banking locations throughout Alabama, Georgia, North Carolina, South Carolina, Tennessee, and Florida, we provide a full range of consumer and commercial banking products to fit your unique needs. If you want a better banking experience, visit your local United Community today and allow our team to deliver the personal attention you deserve. Visit ucbi.com to learn more about the products and services we offer. Before engaging with our online community (including our social media channels), please refer to our Community Guidelines: ucbi.com/social-media The social media policy covers acceptable use by the public and our employees in conjunction with our Privacy Policy: ucbi.com/privacy-policy Equal Housing Lender | Member FDIC.
A-MAX Auto Insurance is a Texas-based insurance provider founded in 2002, with its headquarters in Dallas. The company specializes in affordable insurance solutions and has rapidly expanded to operate over 200 offices across Texas. In 2022, A-MAX entered the California market by acquiring Sameday Insurance, adding 10 locations in Southern California. A-MAX offers a wide range of insurance products, including auto insurance for cars, motorcycles, boats, RVs, and commercial vehicles. They also provide property insurance for homeowners, renters, and mobile homes, along with specialized services such as SR-22 certificates, Mexico tourist insurance, surety bonds, and notary services. Additionally, A-MAX has commercial solutions, including general liability and commercial auto insurance. The company operates two subsidiaries in Texas: ALPA Auto Insurance and Preferred Coverage Insurance Agency, catering to both non-standard and commercial/personal insurance needs. A-MAX focuses on delivering flexible, customer-centric service to individual consumers and businesses.
Bimeda is an Ireland-based company that develops, manufactures and markets veterinary and animal care products.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.